D. E. Shaw & Co., Inc. - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 116 filers reported holding DICE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.21 and the average weighting 1.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$15,027,626
-5.7%
323,453
-41.9%
0.02%
-11.8%
Q1 2023$15,936,305
-25.2%
556,241
-18.6%
0.02%
-29.2%
Q4 2022$21,307,541
+10293.9%
682,934
+6271.8%
0.02%
Q1 2022$205,000
-87.4%
10,718
-83.3%
0.00%
-100.0%
Q4 2021$1,624,00064,1460.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders